Don’t Miss TipRanks’ Half-Year Sale
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
- Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week.
An announcement from Respiri Limited ( (AU:RSH) ) is now available.
Respiri Limited has announced a partnership with Evolent Care Partners and the Hawaii Independent Physicians Association to provide care management services to Medicare patients in Hawaii. This collaboration, starting with approximately 1,800 patients, aims to enhance patient outcomes through a coordinated care approach. The partnership strengthens Respiri’s position in value-based care and remote patient monitoring, with an expected revenue potential of $100-$200 per patient per month. This initiative is part of Respiri’s broader strategy to expand its footprint in the US healthcare market through strategic collaborations.
More about Respiri Limited
Respiri Limited is an innovative eHealth company specializing in remote healthcare solutions, particularly in the US market. They focus on medical devices and MedTech, offering advanced care management programs for chronic conditions, including their unique remote wheeze detection technology. Their disruptive business model integrates cutting-edge technology with clinical expertise to enhance healthcare delivery and reduce costs.
Technical Sentiment Consensus Rating: Hold
Current Market Cap: $44.76M
Learn more about RSH stock on TipRanks’ Stock Analysis page.